Natsumi Inoue

Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis

Masaki Shimizu, Yasuo Nakagishi, Natsumi Inoue et al. · Clinical Immunology · 2015 · 167 citations

Inflammation, Rheumatology, Cytokine +12

Cytokine profile in adult-onset Still's disease: Comparison with systemic juvenile idiopathic arthritis

Natsumi Inoue, Masaki Shimizu, Shinichiro Tsunoda et al. · Clinical Immunology · 2016 · 136 citations · Full text

Inflammation, Rheumatology, Rheumatoid Disorder +12

Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial

Athimalaipet V Ramanan, Pierre Quartier, Nami Okamoto et al. · The Lancet · 2023 · 64 citations · Full text

Rheumatology, Juvenile Idiopathic Arthritis, Pediatrics +9

Clinical significance of serum CXCL9 levels as a biomarker for systemic juvenile idiopathic arthritis associated macrophage activation syndrome

Mao Mizuta, Masaki Shimizu, Natsumi Inoue et al. · Cytokine · 2019 · 52 citations

Inflammation, Rheumatology, Rheumatoid Disorder +13

Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis

Masaki Shimizu, Natsumi Inoue, Mao Mizuta et al. · Clinical & Experimental Immunology · 2017 · 46 citations · Full text